Pfizer

Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, announced a newly expanded, multi-year agreement…

Companies initiate research agreement supporting development of new AI-ECG algorithm to help identify patients who may be at risk of cardiac…

Pfizer Inc. and BioNTech SE announced positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-adapted COVID-19 vaccine…

EUA is based on data that show children 5 through 11 years of age had a robust immune response with a favorable safety profile following a 10-µg…

Pfizer will provide all its current and future patent-protected medicines and vaccines available in the U.S. or EU on a not-for-profit basis to…

Based on topline data, three doses of the Pfizer-BioNTech COVID-19 Vaccine met all immunobridging criteria required for Emergency Use…

CytoReason, a leading developer of computational disease models for efficient drug discovery and development, announced the extension of its…

Alpert brings wealth of experience leading government and political strategy at Walmart, Pfizer, and the White House to the govtech leader Accela,…

AxS Health's Vaccine Reservation and Appointment System has enabled Redlands Community Hospital to provide almost 20,000 Johnson & Johnson, Pfizer…

Michael Vincent, M.D., Ph.D., Chief Scientific Officer, Inflammation & Immunology Research Unit at Pfizer, to join Vedanta’s Scientific…